Drug therapy for the management of cancer related fatigue (Q24244459)

1

0 references

P Stone

2

0 references

A Richardson

3

0 references

M Sharpe

Cochrane Database of Systematic Reviews

4

0 references

publication date

18 July 2007

0 references

published in

0 references

cites work

Meta-analysis in clinical research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

The measurement, causes and effective management of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Fatigue in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Exercise for treatment of cancer related fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Fatigue associated with cancer and its treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Fatigue and psychological distress in the working population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

A population-based incidence study of chronic fatigue.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Management of cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Evidence-based treatment for cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006704

7 January 2021